SynBiotic SE Stock

Equities

SBX

DE000A3E5A59

Pharmaceuticals

Real-time Estimate Tradegate 03:30:28 2024-07-18 am EDT 5-day change 1st Jan Change
7.77 EUR +2.78% Intraday chart for SynBiotic SE +0.80% +152.84%
Sales 2021 9.06 8.29 Sales 2022 8.17 7.47 Capitalization 37.92M 34.68M
Net income 2021 -12M -10.98M Net income 2022 -24M -21.95M EV / Sales 2021 10,783,962 x
Net Debt 2021 215K 196K Net Debt 2022 3.17M 2.9M EV / Sales 2022 5,031,340 x
P/E ratio 2021
-7.04 x
P/E ratio 2022
-1.73 x
Employees 104
Yield 2021 *
-
Yield 2022
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.78%
1 week+0.80%
Current month-6.20%
1 month-8.92%
3 months-24.40%
6 months+119.13%
Current year+152.84%
More quotes
1 week
7.56
Extreme 7.56
8.08
1 month
7.16
Extreme 7.16
8.68
Current year
3.13
Extreme 3.13
16.35
1 year
2.89
Extreme 2.89
16.35
3 years
2.89
Extreme 2.89
43.00
5 years
1.05
Extreme 1.05
43.00
10 years
1.05
Extreme 1.05
43.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 23-08-20
Director of Finance/CFO - 22-12-31
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member - -
More insiders
Date Price Change Volume
24-07-16 7.56 -2.58% 10
24-07-12 7.76 +3.47% 12
24-07-11 7.5 0.00% 12
24-07-10 7.5 -6.25% 500
24-07-09 8 +2.83% 500

End-of-day quote BOERSE DUESSELDORF, July 16, 2024

More quotes
SynBiotic SE is a Germany-based investment company. Mainly the Company invests in cannabinoid focused ventures and teams.
More about the company

Annual profits - Rate of surprise